A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor

Angiogenesis plays an essential role in several diseases of the eye and in the growth of solid tumors, but existing antiangiogenic therapies have limited benefits in several cases. We report the antiangiogenic effects of a monoclonal antibody, CL1-R2, in several animal models of neovascularization....

Descripción completa

Detalles Bibliográficos
Autores principales: Chabot, Sophie, Jabrane-Ferrat, Nabila, Bigot, Karine, Tabiasco, Julie, Provost, Alexandra, Golzio, Muriel, Noman, Muhammad Zaeem, Giustiniani, Jérôme, Bellard, Elisabeth, Brayer, Stéphanie, Aguerre-Girr, Maryse, Meggetto, Fabienne, Giuriato, Sylvie, Malecaze, François, Galiacy, Stéphane, Jaïs, Jean-Philippe, Chose, Olivier, Kadouche, Jean, Chouaib, Salem, Teissié, Justin, Abitbol, Marc, Bensussan, Armand, Le Bouteiller, Philippe
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092350/
https://www.ncbi.nlm.nih.gov/pubmed/21482699
http://dx.doi.org/10.1084/jem.20100810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092350/
https://www.ncbi.nlm.nih.gov/pubmed/21482699
http://dx.doi.org/10.1084/jem.20100810

Ejemplares similares